Status:

UNKNOWN

Breath Control and Mindfulness for Post Concussion Anxiety and Depression: a Feasibility Study

Lead Sponsor:

Western University, Canada

Conditions:

Post-Concussion Syndrome

Anxiety Disorders and Symptoms

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

Persistent-post-concussion symptoms (PPCS) is a condition that effects on average one in seven persons following a concussion. Anxiety and depression symptoms are experienced by over one-third of thos...

Detailed Description

This study will assess the feasibility of a randomized control study designed to remotely deliver a breath control and guided mindfulness exercise to individuals experiencing post-concussion symptoms ...

Eligibility Criteria

Inclusion

  • Ages ≥18 to ≤65 years of age
  • Males and females
  • Ability to comprehend English (written and spoken)
  • Physician-diagnosed concussion ≥ 4weeks prior to commencing study
  • Experiencing post-concussion symptoms (\>0 on the RPQ)
  • Experiencing symptoms of anxiety and/or depression (Score ≥ 5 on the GAD-7 or ≥ 5 on the PHQ-9)
  • Access to an internet accessible device (e.g., computer, smart phone or tablet)
  • Access to a smart device (iOS or Android) (required for use of "Awesome Breathing" application)

Exclusion

  • \<18 or \>65 years of age
  • Score \< 5 on the GAD-7 or \< 5 on the PHQ-9
  • Score 0 on RPQ
  • Inability to comprehend English (written and/or spoken)
  • History of cardiovascular or cardiorespiratory condition
  • History of non-traumatic acquired brain injury
  • History of neurological or neurodevelopment disorder
  • History of unmanaged or managed psychiatric diagnosis (i.e., mental health issue, including bipolar, schizophrenia, etc.)
  • No history substance abuse (drug or alcohol)
  • Current pregnancy
  • Currently attending other yogic or meditation/mindfulness therapy sessions

Key Trial Info

Start Date :

January 1 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

July 1 2021

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT04708522

Start Date

January 1 2021

End Date

July 1 2021

Last Update

January 14 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Western Ontario

London, Ontario, Canada, N6A3K7